Anesthesia of laboratory animals in manufacturing of diagnostic and preventive biomedicines
- Authors: Semakova A.P.1, Germanchuk V.G.1, Rogozhin V.V.1, Shavina N.Y.1, Ovchinnikova M.V.1, Kirilova T.Y.1, Livanova L.F.1, Belyakova N.I.1
-
Affiliations:
- Federal Government Health Institution “Russian Research Anti-Plague Institute “Microbe” of the Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare
- Issue: Vol 10, No 1 (2020)
- Pages: 83-89
- Section: ORIGINAL ARTICLES
- Submitted: 09.12.2018
- Accepted: 10.06.2019
- Published: 05.04.2020
- URL: https://iimmun.ru/iimm/article/view/810
- DOI: https://doi.org/10.15789/2220-7619-AOL-810
- ID: 810
Cite item
Full Text
Abstract
Preparations such as XilaVet, Zoletil 100 as well as Aeranne (Isoflurane) are successfully applied for animal anesthesia in veterinary practice. We assessed a possibility of using parenteral narcosis with Zoletil 100 in combination with muscle relaxant Xila for producer-rabbits involved in manufacturing of natural rabbit serum subsequently deployed for production of diagnostic serum and immunoglobulin preparations. Administration of preparations into auricular vein is easy to do, while animals are sedated immediately allowing for safe fixation on restraining table and causing no additional stress for biomodels. This type of narcosis provides for expected depth of anesthesia and its maintenance until the end of blood-letting procedure. Parameters characterizing the state of cardiovascular system due to anesthetic products remained within the permitted limits. These preparations do not reduce heart beat rate allowing for collecting sufficient blood volumes. Application of inhalation anesthesia with Aeranne in laboratory animals provides for the specified depth of anesthesia and its maintenance until the end of the whole procedure. However, it requires specialized equipment and highly trained personnel with appropriate skills. Usage of Xila as a mono narcosis is not recommended as exhibits weak analgesic effects and strong hypotensive activity by decreasing quantity of collected blood volume. It was found that anesthetics such as Xila, Zoletil 100, Aeranne did not affect specific activity of immune sera in case of total dehematizing procedure. Moreover, antibody titers were not declined throughout entire observation (12 months) period and complied with the requirements of regulatory documentation. In addition, a feasibility of replacing old-fashioned anesthesia method with diethyl ether for a combination of safer contemporary preparations of Zoletil 100 and Xila was demonstrated while manufacturing tableted chemical cholera vaccine in experimental series with suckling rabbits used at diverse stages of raw material verification during surgical interventions. Xila, Zoletil 100, and Aeranne examined by us had no impact on the amount of blood obtained from donor-animals, immunological properties of the sera and ready-to-use diagnostic preparations. Such drugs were safe for all-age animals that comply with the requirements to anesthesia of animal biomodels and producer-animals in manufacturing of immunobiological preparations. Thus, our study allowed to conduct experiments with laboratory animals in a more humane manner.
About the authors
A. P. Semakova
Federal Government Health Institution “Russian Research Anti-Plague Institute “Microbe” of the Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare
Author for correspondence.
Email: Semakova.ap@gmail.com
PhD (Biology), Senior Research Officer of the Department of Experimental Animals with Vivarium.
410005, Saratov, Universitetskaya str., 46, Phone: +7 (8452) 26-21-31 (office)
РоссияV. G. Germanchuk
Federal Government Health Institution “Russian Research Anti-Plague Institute “Microbe” of the Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare
Email: rusrapi@microbe.ru
PhD, MD (Medicine), Associate Professor, Head of the Department of Experimental Animals with Vivarium.
Saratov
РоссияV. V. Rogozhin
Federal Government Health Institution “Russian Research Anti-Plague Institute “Microbe” of the Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare
Email: rusrapi@microbe.ru
Junior Researcher, Department of Diagnostic Preparations.
Saratov
РоссияN. Y. Shavina
Federal Government Health Institution “Russian Research Anti-Plague Institute “Microbe” of the Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare
Email: rusrapi@microbe.ru
Researcher, Department of Experimental Animals with Vivarium.
Saratov
РоссияM. V. Ovchinnikova
Federal Government Health Institution “Russian Research Anti-Plague Institute “Microbe” of the Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare
Email: rusrapi@microbe.ru
PhD (Biology), Head of the Department of Diagnostic Preparations.
Saratov
РоссияT. Y. Kirilova
Federal Government Health Institution “Russian Research Anti-Plague Institute “Microbe” of the Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare
Email: rusrapi@microbe.ru
Researcher, Department of Diagnostic Preparations.
Saratov
РоссияL. F. Livanova
Federal Government Health Institution “Russian Research Anti-Plague Institute “Microbe” of the Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare
Email: rusrapi@microbe.ru
PhD (Biology), Senior Researcher, Department of Prophylactic Preparations.
Saratov
РоссияN. I. Belyakova
Federal Government Health Institution “Russian Research Anti-Plague Institute “Microbe” of the Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare
Email: rusrapi@microbe.ru
PhD (Medicine), Senior Researcher, Department of Prophylactic Preparations.
Saratov
РоссияReferences
- Белоусов Ю.Б., Кукес В.Г., Лепахин В.К., Петров В.И. Клиническая фармакология: национальное руководство. Руководство для врачей. 2-е изд. М.: Универсум паблишинг, 1997. 531 с.
- Бетшарт-Вольфенсбергер Р., Стекольников А.А., Нечаев А.Ю. Ветеринарная анестезиология. Учебное пособие. СПб.: СпецЛит, 2010. 272 с.
- Герасимов Н.М., Гиммельфарб Г.Н., Назарова Т.А. Влияние анестезии и искусственного кровообращения на метаболизм гистамина и серотонина в эксперименте // Медицинский журнал Узбекистана. 1983. № 4. С. 32—35.
- Гиммельфарб Г.Н. Анестезия у экспериментальных животных. Ташкент: ФАН, 1984. 144 с.
- Европейская конвенция по защите позвоночных животных, используемых в экспериментальных и других научных целях. Страсбург. Серия Европейских Договоров. 1986 г. № 123. 48 с.
- КаркищенкоН.Н., Грачев С.В. Руководство полабораторнымживотнымиальтернативныммоделям в биомедицинских технологиях. М., 2010. 173 с.
- Колесов М.А. Анестезиология и реаниматология собак и кошек. М.: ООО «Аквариум-Принт», 2007. 207 с.
- Лихванцев В.В. Опасности и осложнения общей анестезии. М.: ООО «Медицинское информационное агентство», 2014. 200 с.
- Лукъяновский В.А., Самошкин И.Б., Стекольников А.А. Местное и общее обезболивание животных: Учебное пособие. СПб.: Издательство «Лань», 2004. 208 с.
- Об утверждении Правил лабораторной практики (GLP): Приказ Министерства здравоохранения и социального развития Российской Федерации (Минздравсоцразвития России) № 708н. г. от 23 августа 2010 г. Москва.
- Санитарно-эпидемиологические правила СП 1.3.2322-08 «Безопасность работы с микроорганизмами III—IV групп патогенности (опасности) и возбудителями паразитарных болезней» (с изменениями от 2 июня 2009 г.)
- Санитарно-эпидемиологические правила СП 1.3.3118-13 «Безопасность работы с микроорганизмами I—II групп патогенности (опасности) и возбудителями паразитарных болезней».
- Санитарно-эпидемиологические правила СП 2.2.1.3218-14 «Санитарно-эпидемиологические требования к устройству, оборудованию и содержанию экспериментально-биологических клиник (вивариев)».
- Фатеева Е.И., Чернов А.С., Телегин Г.Б. Общие принципы анестезии и аналгезии лабораторных животных // Международный вестник ветеринарии. 2014. № 2. C. 97—103.
- Dutta N.K., Habbu M.K. Experimental cholera in infant rabbits: a metod for chemotherarapeutic investigation. Brit. J. Pharmacol. Chemother, 1955, vol. 10, no. 2, p. 153.
- Scfieller M.S., Told М.М., Drutimond J.C Isoflurane, halothane and regional cerebral blood flow at various levels of PaCO, in rabbits. Anesthesiology, 1986, vol. 64, no. 5, pp. 598— 604.